IP Library Granted Patent US 8,771,759
Granted Patent B2
US 8,771,759 · App. 13/055,081 · Granted Jul 8, 2014

Topical anti-inflammatory combination

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,771,759
App. No.
13/055,081
Granted
Jul 8, 2014
Kind
B2
Abstract

Provided, among other things, is a method of treating or ameliorating an indication of non-mucosal topical tissue comprising periodically applying to such disease affected tissue a composition comprising: an effective amount of an appropriate composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea , and an effective amount of a quaternary ammonium surfactant.

Claims (16)

1. A method of treating or ameliorating an indication of non-mucosal topical tissue that is acne comprising periodically applying to such disease affected tissue a composition comprising

an effective amount of an appropriate composition of herbal extract(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea , and

an effective amount of a quaternary ammonium surfactant.

2. The method of claim 1 , wherein the quaternary ammonium surfactant comprises a 1-alkylpyridinium salt, where alkyl is C8-C36.

3. The method of claim one of the foregoing claims, further comprising applying to a portion of the tissue a film, patch or an adhesive solid formulation comprising appropriate composition of herbal extract(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea.

4. A method of claim 1 , wherein the acne is acne urticata.

5. The method of claim 4 , further comprising applying to a portion of the tissue a film, patch or an adhesive solid formulation comprising appropriate composition of herbal bioactive extract(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea.

6. The method of claim 4 , wherein the extract(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea comprise an antiinflammatory amount.

7. The method of claim 5 , wherein the extract(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea comprise an anti-inflammatory amount.

8. The method of claim 1 ,

wherein Sambucus nigra extract is more than 50% to 90% by weight of the plant extract solids and Centella asiatica is 1% to less than 50% by weight of the plant extract solids, and

the surfactant is a 1-alkylpyridinium salt, where alkyl is C8-C36, the surfactant present in an amount from 0.01 to 5% of the formulation by weight.

9. The method of claim 4 , wherein the quaternary ammonium surfactant comprises a 1-alkylpyridinium salt, where alkyl is C8-C36.

10. The method of claim 4 ,

wherein Sambucus nigra extract is more than 50% to 90% by weight of the plant extract solids and Centella asiatica is 1% to less than 50% by weight of the plant extract solids, and

the surfactant is a 1-alkylpyridinium salt, where alkyl is C8-C36, the surfactant present in an amount from 0.01 to 5% of the formulation by weight.

Assignments (5)
SECURITY INTEREST Recorded Jun 30, 2021
From: IZUN PHARMACEUTICALS CORPORATION
To: JONATHAN KALMAN
Reel/Frame 056716/0583 →
RELEASE OF SECURITY INTEREST Recorded Jan 8, 2019
From: IZUN PHARMACEUTICALS CORPORATION
To: HAHN, ELLIOT F
Reel/Frame 047934/0363 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBERS 14193345 AND 15006421 PREVIOUSLY RECORDED AT REEL: 040824 FRAME: 0202. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Dec 28, 2017
From: IZUN PHARMACEUTICALS CORPORATION
To: HAHN, ELLIOT F
Reel/Frame 045032/0099 →
SECURITY AGREEMENT Recorded Dec 6, 2016
From: IZUN PHARMACEUTICALS CORPORATION
To: HAHN, ELLIOT F
Reel/Frame 040824/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2011
From: LEVINE, WILLIAM ZEV; SAFFER, ARON JAY; NUSSBAUM, GABRIEL
To: IZUN PHARMACEUTICALS INC.
Reel/Frame 025837/0053 →